December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Novel Mutations in the PRPC8 Gene, Encoding a Pre-mRNA Splicing Factor in Patients with Autosomal Dominant Retinitis Pigmentosa
Author Affiliations & Notes
  • AC De Erkenez
    Ocular Molecular Genetics Institute
    Harvard Medical School Masschusetts Eye and Ear Infirmary Boston MA
  • EL Berson
    The Berman-Gund Laboratory for the Study of Retinal Degenerations
    Harvard Medical School Masschusetts Eye and Ear Infirmary Boston MA
  • TP Dryja
    Ocular Molecular Genetics Institute
    Harvard Medical School Masschusetts Eye and Ear Infirmary Boston MA
  • Footnotes
    Commercial Relationships   A.C. De Erkenez, None; E.L. Berson, None; T.P. Dryja, None. Grant Identification: The Foundation Fighting Blindness EY08683, EY00169s
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 791. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      AC De Erkenez, EL Berson, TP Dryja; Novel Mutations in the PRPC8 Gene, Encoding a Pre-mRNA Splicing Factor in Patients with Autosomal Dominant Retinitis Pigmentosa . Invest. Ophthalmol. Vis. Sci. 2002;43(13):791.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To screen patients with autosomal dominant retinitis pigmentosa (RP) for mutations in the PRPC8 gene, located on chromosome 17p13.3. Missense mutations in this gene were recently described as the cause of dominant RP in seven patients (Inglehearn et al., Hum.Mol.Genet.10:1555,2001). Although the entire gene had been screened, all reported mutations were located within a 42-bp sequence (14 codons) in the last exon (exon 42). Methods: We are screening exons 41 and 42 by designing oligonucleotide primers based on the flanking intron sequences and the 3’ untranslated region. Using these primers, we separately amplify the two exons in 190 unrelated patients with autosomal dominant RP. Amplified fragments are examined by single-strand conformation (SSCP) analysis. DNA samples with an SSCP variant are directly sequenced. Results: We have identified four patients each with a different mutation in the PRPC8 gene. All four patients are heterozygotes. Three mutations are novel: a frameshift due to a 1-bp deletion (Glu2331, 1-bp del, GAG≷-AG), a nonsense mutation (Gln2321End, CAG≷TAG), and a missense mutation (Tyr2334Asn, TAT≷AAT). Segregation analysis was performed on 23 family members of the index patient with the mutation Tyr2334Asn. Twelve relatives of this patient were heterozygous for the mutation: eleven of these were affected and one; was asymptomatic by history but has yet to be clinically examined. No segregation analysis has yet been performed on the families with the novel mutations (Glu2331, 1-bp del) and (Gln2321TER). The fourth mutation, Arg2310Gly (AGG≷GGG), has been previously described. Conclusion: Our frameshift and nonsense mutations are the first mutations of these types discovered so far in this gene, and they support the idea that the carboxyl-terminal region of the encoded protein is essential to retinal function. With the majority of the screening of the PRPC8 gene complete, we are currently evaluating whether the other novel mutations cosegregate with RP.

Keywords: 420 genetics • 480 mutations • 562 retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×